39 results on '"Bocci, Guido"'
Search Results
2. Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib
3. The impact of survivorship bias in glioblastoma research
4. Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?
5. Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients
6. Relevant pharmacological interactions between alkylating agents and antiepileptic drugs: Preclinical and clinical data
7. Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds
8. New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects
9. Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation
10. Pharmacological effects of vinorelbine in combination with lenvatinib in anaplastic thyroid cancer
11. Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours?
12. Chemotherapeutic and antiangiogenic drugs beyond tumor progression in colon cancer: Evaluation of the effects of switched schedules and related pharmacodynamics
13. Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data
14. Metronomic vinorelbine is directly active on Non Small Cell Lung Cancer cells and sensitizes the EGFRL858R/T790M cells to reversible EGFR tyrosine kinase inhibitors
15. Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer
16. Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients
17. Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2
18. Antineoplastic activity of the multitarget tyrosine kinase inhibitors CLM3 and CLM94 in medullary thyroid cancer in vitro
19. CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo
20. Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections
21. Prospective Analysis of the Early Modulation of Plasma Amphiregulin During Treatment with Cetuximab and Irinotecan in Metastatic Colorectal Cancer Patients
22. Metronomic Ceramide Analogs Inhibit Angiogenesis in Pancreatic Cancer through Up-regulation of Caveolin-1 and Thrombospondin-1 and Down-regulation of Cyclin D1
23. P-0262 Prospective Evaluation of Candidate Snps of Vegf/Vegfr Pathway in Metastatic Colorectal Cancer Patients Treated with First-Line Folfiri Plus Bevacizumab (BV)
24. The possible role of chemotherapy in antiangiogenic drug resistance
25. Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?
26. ALK-1–Negative Anaplastic Large Cell Lymphoma Associated With Breast Implants: A New Clinical Entity
27. Antiproliferative and proapoptotic activity of CLM3, a novel multiple tyrosine kinase inhibitor, alone and in combination with SN-38 on endothelial and cancer cells
28. Irinotecan Synergistically Enhances the Antiproliferative and Proapoptotic Effects of Axitinib In Vitro and Improves Its Anticancer Activity In Vivo
29. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer
30. In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma
31. 5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in mice
32. Importance of Preclinical Investigations of the Integration of Capecitabine into Polychemotherapy Regimens
33. Antiangiogenic versus cytotoxic therapeutic approaches to human pancreas cancer: an experimental study with a vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor and gemcitabine
34. Biologic Basis of Ovarian Metastasis of Colorectal Cancer
35. Three-dimensional in vitro culture of endometrial explants mimics the early stages of endometriosis
36. Selective anti-endothelial effects of protracted low-dose BAL-9504, a novel geranylgeranyl-transferase inhibitor
37. The effect of osteogenic growth peptide (OGP) on proliferation and adhesion of HEMC-1 human endothelial cells
38. Synergistic chemotherapeutic activity of gemcitabine and fluvastatin on pancreas cancer in vitro
39. The Heparan Sulfate Suleparoide Inhibits Rat Corneal Angiogenesis and in vitro Neovascularization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.